Ranliang Cui

机构：Tianjin Medical University Cancer Institute and Hospital

发表论文 13 篇 · 总被引 124 次 · h-index 6

代表论文

• <p>Clinical value of ROMA index in diagnosis of ovarian cancer: meta-analysis</p> (2019 · Cancer Management and Research · 被引 50)
• Role of Carboxypeptidase N Invasion and Migration in Breast Cancer (2016 · Anti-Cancer Agents in Medicinal Chemistry · 被引 15)
• Hypoxia-Induced TGFBI as a Serum Biomarker for Laboratory Diagnosis and Prognosis in Patients with Pancreatic Ductal Adenocarcinoma (2019 · Laboratory Medicine · 被引 14)
• Serum Carboxypeptidase N1 Serves as a Potential Biomarker Complementing CA15-3 for Breast Cancer (2020 · Anti-Cancer Agents in Medicinal Chemistry · 被引 13)
• Hepatocyte-specific C-C motif chemokine ligand 9 signaling promotes liver fibrosis progression in mice (2025 · Hepatology · 被引 9)
• Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer (2021 · Cancer Cell International · 被引 9)